• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Annual U.K. SHOT Report on Serious Hazards of Transfusions

July 26, 2023

The Royal College of Pathologists in the United Kingdom recently published their annual report for 2022 on the Serious Hazards of Transfusions (SHOT).  The total number of whole blood donations in the U.K. in 2022 was just over 1.8 million.  Although transfusions are a common and relatively safe procedure, the U.K. collects hemovigilance data on all serious adverse reactions (SAR) and serious adverse events (SAE) related to transfusions.  After years of continued improvement in safety, reports of SAR and SAE in transfusions have increased two years in a row and have doubled since 2020.  In the U.K. in 2022, 3499 SAR and SAE were reported, 83.1% of which were errors. “Near misses” were the most common type of report with 1366/3499 (39.0% of reports) with anti-D immunization reports (n=345) and the incorrect blood component transfused (n=296) the next two most common reports.  In total, 35 patients who received transfusion support died with the leading causes being delays in transfusion (n=13) and transfusion-associated circulatory overload (TACO) (n=8).  In addition, two patients died due to ABO incompatibility issues, which occurred due to a series of mistakes and shortcuts.  The chair of the SHOT committee, noted the lack of improvement and stressed communication and training of staff and adherence to protocol no matter how busy or stressful the situation.

Reference:

Annual Shot Report 2022.  Royal College of Pathologists. 

Filed Under

  • Adverse Events (non-infectious)
  • News
  • Quality Control and Regulatory

Recommended

  • U.S. FDA Advises Blood Community Regarding Monkeypox Virus

  • New Platelet Transfusion Guidelines from the International Collaboration for Transfusion Medicine

  • Red Blood Cell Transfusion Increases Platelet Aggregation in Anemic Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley